Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.95 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.95 |
| ▸ | HPGD | P15428 | 6/20 | 0.95 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.95 |
| ▸ | CA12 | O43570 | 2/20 | 0.95 |
| ▸ | CA1 | P00915 | 2/20 | 0.95 |
| ▸ | CA2 | P00918 | 2/20 | 0.95 |
| ▸ | CA7 | P43166 | 2/20 | 0.95 |
| ▸ | CA9 | Q16790 | 2/20 | 0.95 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.95 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.95 |
| ▸ | CA4 | P22748 | 1/20 | 0.95 |
| ▸ | CA6 | P23280 | 1/20 | 0.95 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.95 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | G6PD | P11413 | 1/20 | 0.58 |
| ▸ | CASP7 | P55210 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Salicylic Acid SCHEMBL29362663 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL8433746 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL29360246 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL1967 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL1509155 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL17156443 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL29606432 | 0.97 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL971594 | 0.95 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL162965 | 0.95 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 | |
| Salicylic Acid SCHEMBL8599857 | 0.95 | ALDH1A1 (0.95) | ALDH1A1KDM4EHPGDSMN1; SMN2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423168-B1 | POLYETHER POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250115711-A1 | POLYETHER POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-04-10 | — | — | US | disclosed |
| US-12201971-B2 | Polyether polymerization process | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-01-21 | — | — | US | disclosed |
| US-20240392068-A1 | POLYETHER POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-11-28 | — | — | US | disclosed |
| US-12152104-B2 | Polyether polymerization process | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-11-26 | — | — | US | disclosed |
| EP-4423170-A2 | POLYETHER POLYMERIZATION PROCESS | Dow Global Technologies LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-4423168-A1 | POLYETHER POLYMERIZATION PROCESS | Dow Global Technologies LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| CN-118043376-A | Polyether polymerization process | 陶氏环球技术有限责任公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-118043375-A | Polyether polymerization process | 陶氏环球技术有限责任公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-113195591-B | Polyether polymerization process | 陶氏环球技术有限责任公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-3622002-A1 | CATALYST COMPLEX | Dow Global Technologies, LLC (US) | 2020-03-18 | — | — | EP | disclosed |
| CN-110869416-A | Catalyst complex | 陶氏环球技术有限责任公司 | 2020-03-06 | — | — | CN | disclosed |
| CN-110832007-A | Polyether polymerization process | 陶氏环球技术有限责任公司 | 2020-02-21 | — | — | CN | disclosed |
| WO-2018209075-A1 | POLYETHER POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-11-15 | — | — | WO | disclosed |
| WO-2018209069-A1 | CATALYST COMPLEX | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-11-15 | — | — | WO | disclosed |
| CN-106623962-A | Method for preparing nanometer tungsten powder by organizing sodium tungstate | 湖南省华京粉体材料有限公司 | 2017-05-10 | — | — | CN | disclosed |
| US-20140066758-A1 | SPINAL IMPLANT SYSTEM AND METHODS OF USE | WARSAW ORTHOPEDIC, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-20050287071-A1 | Formulation for a cement preparation as bone substitute | KYPHON INC. (US) | 2005-12-29 | — | — | US | disclosed |
| EP-1560609-A1 | FORMULATION FOR A CEMENT PREPARATION AS BONE SUBSTITUTE | Kyphon Inc. (US) | 2005-08-10 | — | — | EP | disclosed |
| WO-2004050131-A1 | FORMULATION FOR A CEMENT PREPARATION AS BONE SUBSTITUTE | KYPHON INC. (US) | 2004-06-17 | — | — | WO | disclosed |